Public Consultation on Greater Transparency for GMP Inspection Outcomes

The Therapeutic Goods Administration (TGA) has commenced a public consultation on a proposal to increase transparency regarding Good Manufacturing Practice (GMP) inspection outcomes for manufacturers of pharmaceutical products supplied to Australia.